Ratings by Piper Sandler (David Amsellem)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/18/2021 Harmony Biosciences Holdings Inc. HRMY Maintain Overweight
(N/A)
 
 
  Details
6/15/2021 Xeris Pharmaceuticals XERS Maintain Overweight
(N/A)
 
 
  Details
5/24/2021 Jazz Pharmaceuticals JAZZ Maintain Overweight
(N/A)
 
 
  Details
5/11/2021 Revance Therapeutic RVNC Maintain Overweight
(N/A)
 
 
  Details
5/7/2021 Collegium Pharmaceutical COLL Maintain Overweight
(N/A)
 
 
  Details
5/7/2021 Evofem Biosciences Inc EVFM Maintain Overweight
(N/A)
 
 
  Details
5/6/2021 Baudax Bio Inc. BXRX Maintain Overweight
(N/A)
 
 
  Details
5/6/2021 Neurocrine Bio. NBIX Maintain Overweight
(N/A)
 
 
  Details
4/27/2021 Jazz Pharmaceuticals JAZZ Maintain Overweight
(N/A)
 
 
  Details
4/19/2021 Endo International plc ENDP Maintain Overweight
(N/A)
 
 
  Details
4/6/2021 Cara Therapeutics CARA Maintain Overweight
(N/A)
 
 
  Details
3/3/2021 Eagle Pharmaceuticals EGRX Maintain Neutral
(N/A)
 
 
  Details
2/25/2021 Bausch Health Companies BHC Maintain Neutral
(N/A)
 
 
  Details
2/24/2021 Jazz Pharmaceuticals JAZZ Maintain Overweight
(N/A)
 
 
  Details
2/10/2021 Baudax Bio Inc. BXRX Maintain Overweight
(N/A)
 
 
  Details
2/10/2021 Antares Pharma ATRS Maintain Overweight
(N/A)
 
 
  Details
2/10/2021 Adamas Pharmaceuticals ADMS Maintain Overweight
(N/A)
 
 
  Details
2/10/2021 Revance Therapeutic RVNC Maintain Overweight
(N/A)
 
 
  Details
2/10/2021 Collegium Pharmaceutical COLL Maintain Overweight
(N/A)
 
 
  Details
2/5/2021 Horizon Therapeutics HZNP Maintain Overweight
(N/A)
 
 
  Details
2/3/2021 Jazz Pharmaceuticals JAZZ Upgrade Overweight
(Neutral)
157.29
(177.28)
12.71% Details
1/20/2021 Pacira Pharmaceuticals PCRX Maintain Overweight
(N/A)
 
 
  Details
1/4/2021 Endo International plc ENDP Maintain Overweight
(N/A)
 
 
  Details
11/6/2020 Collegium Pharmaceutical COLL Maintain Overweight
(N/A)
 
 
  Details
11/5/2020 Bausch Health Companies BHC Maintain Overweight
(N/A)
 
 
  Details
10/9/2020 Amneal Pharmaceuticals AMRX Maintain Overweight
(N/A)
 
 
  Details
10/9/2020 Endo International plc ENDP Maintain Overweight
(N/A)
 
 
  Details
9/29/2020 Xeris Pharmaceuticals XERS Maintain Overweight
(N/A)
 
 
  Details
9/14/2020 Harmony Biosciences Holdings Inc. HRMY New Coverage Overweight
(N/A)
44.39
(31.31)
-29.47% Details
8/19/2020 Bausch Health Companies BHC Maintain Overweight
(N/A)
 
 
  Details
8/4/2020 Mallinckrodt plc MNK Downgrade Underweight
(Neutral)
2.26
(0.75)
-66.81% Details
8/4/2020 Neurocrine Bio. NBIX Maintain Overweight
(N/A)
 
 
  Details
7/22/2020 Horizon Therapeutics HZNP Maintain Overweight
(N/A)
 
 
  Details
6/16/2020 Supernus Pharmaceuticals SUPN Upgrade Overweight
(Neutral)
22.83
(32.09)
40.56% Details
6/8/2020 Evofem Biosciences Inc EVFM New Coverage Overweight
(N/A)
3.31
(1.10)
-66.77% Details
6/5/2020 Horizon Therapeutics HZNP Maintain Overweight
(N/A)
 
 
  Details
6/1/2020 Neurocrine Bio. NBIX Maintain Overweight
(Overweight)
 
 
  Details
5/21/2020 Horizon Therapeutics HZNP Maintain Overweight
(N/A)
 
 
  Details
5/15/2020 Teva Pharma TEVA Maintain Neutral
(N/A)
 
 
  Details
5/6/2020 Jazz Pharmaceuticals JAZZ Maintain Neutral
(N/A)
 
 
  Details
5/4/2020 Avadel Pharmaceuticals AVDL Maintain Overweight
(N/A)
 
 
  Details
3/9/2020 Mallinckrodt plc MNK Maintain Neutral
(N/A)
 
 
  Details
3/3/2020 Eagle Pharmaceuticals EGRX Maintain Neutral
(N/A)
 
 
  Details
2/28/2020 Mylan MYL Maintain Neutral
(N/A)
 
 
  Details
2/28/2020 Collegium Pharmaceutical COLL Maintain Overweight
(N/A)
 
 
  Details
2/27/2020 Supernus Pharmaceuticals SUPN Maintain Neutral
(N/A)
 
 
  Details
2/26/2020 Jazz Pharmaceuticals JAZZ Maintain Neutral
(N/A)
 
 
  Details
2/26/2020 Avadel Pharmaceuticals AVDL New Coverage Overweight
(N/A)
10.64
(7.85)
-26.22% Details
2/25/2020 Revance Therapeutic RVNC Maintain Overweight
(N/A)
 
 
  Details
2/21/2020 Baudax Bio Inc. BXRX Maintain Overweight
(N/A)
 
 
  Details
2/20/2020 Pacira Pharmaceuticals PCRX Maintain Overweight
(N/A)
 
 
  Details
2/20/2020 Bausch Health Companies BHC Maintain Overweight
(N/A)
 
 
  Details
2/18/2020 Revance Therapeutic RVNC Maintain Overweight
(N/A)
 
 
  Details
2/18/2020 Xeris Pharmaceuticals XERS New Coverage Overweight
(N/A)
4.13
(4.11)
-0.48% Details
2/14/2020 Baudax Bio Inc. BXRX Maintain Overweight
(N/A)
 
 
  Details
2/13/2020 Teva Pharma TEVA Maintain Neutral
(N/A)
 
 
  Details
2/12/2020 Collegium Pharmaceutical COLL Maintain Overweight
(N/A)
 
 
  Details
2/5/2020 Neurocrine Bio. NBIX Maintain Overweight
(N/A)
 
 
  Details
1/9/2020 Mylan MYL New Coverage Neutral
(N/A)
21.17
(15.86)
-25.08% Details
1/9/2020 BioDelivery Sciences International BDSI New Coverage Overweight
(N/A)
5.71
(3.64)
-36.25% Details
1/6/2020 Novan NOVN Downgrade Neutral
(Overweight)
3.11
(10.87)
249.52% Details
1/3/2020 Endo International plc ENDP Upgrade Overweight
(Neutral)
4.69
(5.22)
11.3% Details
12/30/2019 Bausch Health Companies BHC Maintain Overweight
(N/A)
 
 
  Details
12/17/2019 Adamas Pharmaceuticals ADMS Maintain Overweight
(N/A)
 
 
  Details
12/13/2019 Amneal Pharmaceuticals AMRX Maintain Overweight
(N/A)
 
 
  Details
12/12/2019 Neurocrine Bio. NBIX Maintain Overweight
(N/A)
 
 
  Details
12/9/2019 Revance Therapeutic RVNC Maintain Overweight
(N/A)
 
 
  Details
11/22/2019 Baudax Bio Inc. BXRX New Coverage Overweight
(N/A)
0.00
(0.78)
0% Details
11/13/2019 Optinose OPTN Maintain Overweight
(N/A)
 
 
  Details
11/8/2019 Teva Pharma TEVA Maintain Neutral
(N/A)
 
 
  Details
11/8/2019 Amphastar Pharmaceuticals AMPH Maintain Neutral
(N/A)
 
 
  Details
11/8/2019 Adamas Pharmaceuticals ADMS Maintain Overweight
(N/A)
 
 
  Details
11/7/2019 Collegium Pharmaceutical COLL Maintain Overweight
(N/A)
 
 
  Details
11/7/2019 Amneal Pharmaceuticals AMRX Maintain Overweight
(N/A)
 
 
  Details
11/5/2019 Revance Therapeutic RVNC Maintain Overweight
(N/A)
 
 
  Details
11/5/2019 Neurocrine Bio. NBIX Maintain Overweight
(N/A)
 
 
  Details
8/21/2019 Jazz Pharmaceuticals JAZZ Downgrade Neutral
(Overweight)
136.45
(157.29)
15.27% Details
8/13/2019 Optinose OPTN Maintain Overweight
(N/A)
 
 
  Details
8/9/2019 Recro Pharma REPH Maintain Overweight
(N/A)
 
 
  Details
8/9/2019 Adamas Pharmaceuticals ADMS Maintain Overweight
(N/A)
 
 
  Details
8/7/2019 Jazz Pharmaceuticals JAZZ Maintain Overweight
(N/A)
 
 
  Details
8/7/2019 Allergen AGN Maintain Neutral
(N/A)
 
 
  Details
8/6/2019 Revance Therapeutic RVNC Maintain Overweight
(N/A)
 
 
  Details
7/30/2019 Neurocrine Bio. NBIX Maintain Overweight
(N/A)
 
 
  Details
7/30/2019 Cara Therapeutics CARA Maintain Overweight
(N/A)
 
 
  Details
7/8/2019 Amneal Pharmaceuticals AMRX Upgrade Overweight
(Neutral)
6.97
(120.40)
1627.4% Details
5/31/2019 Mallinckrodt plc MNK Downgrade Neutral
(Overweight)
9.30
(2.26)
-75.7% Details
5/7/2019 Akorn AKRX Maintain Overweight
(N/A)
 
 
  Details
5/2/2019 Pacira Pharmaceuticals PCRX Maintain Overweight
(N/A)
 
 
  Details
4/30/2019 Neurocrine Bio. NBIX Maintain Overweight
(N/A)
 
 
  Details
4/29/2019 Endo International plc ENDP Maintain Neutral
(N/A)
 
 
  Details
4/9/2019 Pacira Pharmaceuticals PCRX Maintain Overweight
(N/A)
 
 
  Details
4/4/2019 Horizon Pharma HZNP Maintain Overweight
(N/A)
 
 
  Details
3/13/2019 Cara Therapeutics CARA Maintain Overweight
(N/A)
 
 
  Details
3/13/2019 Amphastar Pharmaceuticals AMPH Downgrade Neutral
(Overweight)
23.72
(20.17)
-14.97% Details
3/5/2019 Adamas Pharmaceuticals ADMS Maintain Overweight
(N/A)
 
 
  Details
3/5/2019 Adamas Pharmaceuticals ADMS Maintain Overweight
(N/A)
 
 
  Details
3/1/2019 Endo International plc ENDP Maintain Neutral
(N/A)
 
 
  Details
3/1/2019 Amneal Pharmaceuticals AMRX Maintain Neutral
(N/A)
 
 
  Details
3/1/2019 Akorn AKRX Maintain Overweight
(N/A)
 
 
  Details
2/27/2019 Mallinckrodt plc MNK Maintain Overweight
(N/A)
 
 
  Details
2/27/2019 Jazz Pharmaceuticals JAZZ Maintain Overweight
(N/A)
 
 
  Details
2/6/2019 Neurocrine Bio. NBIX Maintain Overweight
(N/A)
 
 
  Details
1/30/2019 Allergen AGN Maintain Neutral
(N/A)
 
 
  Details
1/23/2019 Teva Pharma TEVA Upgrade Neutral
(Underweight)
18.82
(10.12)
-46.23% Details
1/14/2019 Horizon Pharma HZNP Maintain Overweight
(N/A)
 
 
  Details
1/2/2019 Bausch Health Companies BHC Upgrade Overweight
(Neutral)
18.47
(29.31)
58.69% Details
11/8/2018 Recro Pharma REPH Maintain Overweight
(N/A)
 
 
  Details
11/7/2018 Jazz Pharmaceuticals JAZZ Maintain Overweight
(N/A)
 
 
  Details
11/6/2018 Neurocrine Bio. NBIX Maintain Overweight
(N/A)
 
 
  Details
11/1/2018 Pacira Pharmaceuticals PCRX Maintain Overweight
(N/A)
 
 
  Details
10/31/2018 Eagle Pharmaceuticals EGRX Downgrade Neutral
(Overweight)
56.90
(42.89)
-24.62% Details
10/24/2018 Amneal Pharmaceuticals AMRX Maintain Neutral
(N/A)
 
 
  Details
10/19/2018 Jazz Pharmaceuticals JAZZ Maintain Overweight
(N/A)
 
 
  Details
10/17/2018 Akorn AKRX Upgrade Overweight
(Neutral)
6.26
(0.09)
-98.56% Details
10/9/2018 Pacira Pharmaceuticals PCRX Maintain Overweight
(Overweight)
 
 
  Details
10/2/2018 Akorn AKRX Maintain Neutral
(N/A)
 
 
  Details
9/17/2018 Teva Pharma TEVA Maintain Underweight
(Underweight)
 
 
  Details
9/17/2018 Allergen AGN Maintain Neutral
(N/A)
 
 
  Details
9/17/2018 Revance Therapeutic RVNC Maintain Overweight
(N/A)
 
 
  Details
9/17/2018 Horizon Pharma HZNP Maintain Overweight
(N/A)
 
 
  Details
9/13/2018 Bausch Health Companies BHC Upgrade Neutral
(Underweight)
23.54
(18.47)
-21.54% Details
8/17/2018 Antares Pharma ATRS Maintain Overweight
(N/A)
 
 
  Details
8/14/2018 Optinose OPTN Maintain Overweight
(N/A)
 
 
  Details